---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-025080"
form_type: "8-K"
ticker: "PVCT"
cik: "0000315545"
company_name: "PROVECTUS BIOPHARMACEUTICALS, INC."
filed_at: "2024-06-25T23:59:59+00:00"
generated_at: "2026-06-01T02:19:52.410549+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Provectus redeems 11.4M Series D shares for 1.14M Series D-1 shares; authorized share counts amended

## Summary
- VP and President Dominic Rodrigues forfeits 11,416,262 Series D Preferred shares for 1,141,626 Series D-1 shares.
- Series D authorized shares reduced from 12,374,000 to 957,100; Series D-1 increased from 11,241,000 to 23,042,900.
- Company states new Series D-1 shares are economically equivalent to the forfeited Series D shares.
- Amendments to certificates of designation filed with Delaware Secretary of State on June 24, 2024.

## SEC filing metadata
- accession: 0001493152-24-025080
- form_type: 8-K
- ticker: PVCT
- cik: 0000315545
- company_name: PROVECTUS BIOPHARMACEUTICALS, INC.
- filed_at: 2024-06-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/315545/000149315224025080/0001493152-24-025080-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/315545/000149315224025080/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-025080
- JSON: https://secwatch.observer/filing/0001493152-24-025080.json
- Plain text: https://secwatch.observer/filing/0001493152-24-025080.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.